首页> 外文期刊>Statistics and Its Interface >False-negative-rate based approach selecting top single-nucleotide polymorphisms in the first stage of a two-stage genome-wide association study
【24h】

False-negative-rate based approach selecting top single-nucleotide polymorphisms in the first stage of a two-stage genome-wide association study

机译:两阶段全基因组关联研究的第一阶段,基于假阴性率的方法选择顶级单核苷酸多态性

获取原文
           

摘要

Genome-wide association (GWA) studies, where hundreds of thousands of single-nucleotide polymorphisms (SNPs) are tested simultaneously, are becoming popular for identifying disease loci for common diseases. Most commonly, a GWA study involves two stages: the first stage includes testing the association between all SNPs and the disease and the second stage includes replication of SNPs selected from the first stage to validate associations in an independent sample. The first stage is considered to be more fundamental since the second stage is contingent on the results of the first stage. Selection of SNPs from stage one for genotyping in stage two is typically based on an arbitrary threshold or controlling type I errors. These strategies can be inefficient and have the potential to exclude genotyping of disease-associated SNPs in stage two. We propose an approach for selecting top SNPs that uses a strategy based on the false-negative rate (FNR). Using the FNR approach, we proposed the number of SNPs that should be selected based on the observed p-values and a pre-specified multi-testing power in the first stage. We applied our method to simulated data and a GWA study of glioma (a rare form of brain tumor) data. Results from simulation and the glioma GWA indicate that the proposed approach provides an FNR-based way to select SNPs using pre-specified power.
机译:全基因组关联(GWA)研究正在同时检测成千上万的单核苷酸多态性(SNP),目前已广泛用于鉴定常见疾病的疾病位点。最常见的GWA研究涉及两个阶段:第一阶段包括测试所有SNP与疾病之间的关联,第二阶段包括复制从第一阶段中选择的SNP以验证独立样本中的关联。由于第二阶段取决于第一阶段的结果,因此第一阶段被认为更为基础。从第一阶段选择SNP进行第二阶段的基因分型通常是基于任意阈值或控制I型错误。这些策略可能效率低下,并且有可能在第二阶段排除与疾病相关的SNP的基因分型。我们提出了一种使用基于假阴性率(FNR)的策略选择顶级SNP的方法。使用FNR方法,我们建议在第一阶段基于观察到的p值和预先指定的多重测试能力来选择SNP的数量。我们将我们的方法应用于模拟数据和胶质瘤(一种罕见形式的脑肿瘤)数据的GWA研究。仿真和神经胶质瘤GWA的结果表明,所提出的方法提供了一种基于FNR的方法,可以使用预先指定的功率来选择SNP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号